NBI components
The NASDAQ Biotechnology constituents can be found in the table below. Sort NBI stock components by various financial metrics and data such as performance, dividends, income statement and balance sheet.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLC Sponsored ADRDR | 263.53 B USD | 85.31 USD | +1.98% | 5.87 M | 0.95 | 32.00 | 2.67 USD | +29.16% | 1.80% | Health technology | Buy |
 AMGNAmgen Inc. | 160.37 B USD | 297.89 USD | +0.16% | 2.52 M | 0.76 | 24.37 | 12.22 USD | +110.59% | 3.15% | Health technology | Buy |
 GILDGilead Sciences, Inc. | 139.83 B USD | 112.69 USD | +1.93% | 8.09 M | 0.93 | 22.42 | 5.03 USD | +514.42% | 2.79% | Health technology | Buy |
 SNYSanofi SA Sponsored ADRDR | 123.99 B USD | 50.90 USD | +1.52% | 3.73 M | 0.70 | 12.71 | 4.01 USD | +120.81% | 3.14% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 103.4 B USD | 403.30 USD | −1.36% | 1.32 M | 0.64 | 28.83 | 13.99 USD | — | 0.00% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 63.59 B USD | 600.00 USD | 0.00% | 1.15 M | 0.87 | 15.12 | 39.69 USD | +5.10% | 0.44% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 59.82 B USD | 456.35 USD | −1.01% | 969.09 K | 0.89 | — | −2.47 USD | −310.00% | 0.00% | Health technology | Buy |
 ARGXargenx SE Sponsored ADRDR | 48.94 B USD | 800.00 USD | +1.06% | 353.76 K | 0.96 | 40.67 | 19.67 USD | — | 0.00% | Health technology | Strong buy |
 ONCBeOne Medicines Ltd. Sponsored ADRDR | 42.57 B USD | 343.87 USD | −0.38% | 163.18 K | 0.73 | — | −1.72 USD | +66.32% | 0.00% | Health technology | Strong buy |
 INSMInsmed Incorporated | 33.22 B USD | 157.16 USD | +2.85% | 3.49 M | 1.41 | — | −5.70 USD | −5.65% | 0.00% | Health technology | Strong buy |
 BNTXBioNTech SE Sponsored ADRDR | 25.36 B USD | 105.49 USD | +0.94% | 535.71 K | 0.65 | — | −1.60 USD | +30.82% | 0.00% | Health technology | Buy |
 BIIBBiogen Inc. | 23.44 B USD | 159.88 USD | +2.98% | 2.88 M | 1.43 | 15.30 | 10.45 USD | +31.65% | 0.00% | Health technology | Buy |
 RPRXRoyalty Pharma plc | 21.04 B USD | 36.07 USD | −1.15% | 2.21 M | 0.36 | 15.70 | 2.30 USD | +52.85% | 2.41% | Health technology | Strong buy |
 UTHRUnited Therapeutics Corporation | 20.49 B USD | 453.07 USD | +2.17% | 796.29 K | 0.75 | 17.69 | 25.61 USD | +17.66% | 0.00% | Health technology | Buy |
 GMABGenmab A/S Sponsored ADRDR | 20.23 B USD | 33.56 USD | +4.48% | 4.16 M | 1.68 | 16.75 | 2.00 USD | +64.43% | 0.00% | Health technology | Buy |
 INCYIncyte Corporation | 16.96 B USD | 86.85 USD | +0.66% | 1.3 M | 0.69 | 19.74 | 4.40 USD | +1,139.45% | 0.00% | Health technology | Buy |
 TEMTempus AI, Inc. | 15.92 B USD | 91.66 USD | +2.64% | 9.31 M | 0.94 | — | −1.18 USD | +76.46% | 0.00% | Technology services | Buy |
 SMMTSummit Therapeutics Inc. | 15.92 B USD | 21.43 USD | +2.68% | 2.24 M | 0.57 | — | −1.01 USD | −338.19% | 0.00% | Health technology | Buy |
 ILMNIllumina, Inc. | 15.7 B USD | 102.12 USD | +2.84% | 1.68 M | 0.86 | 12.93 | 7.90 USD | — | 0.00% | Health technology | Buy |
 MEDPMedpace Holdings, Inc. | 14.96 B USD | 532.49 USD | −0.69% | 292.59 K | 0.90 | 39.60 | 13.45 USD | +26.42% | 0.00% | Commercial services | Sell |
 NBIXNeurocrine Biosciences, Inc. | 13.59 B USD | 137.03 USD | +0.21% | 1.22 M | 1.19 | 40.45 | 3.39 USD | +2.34% | 0.00% | Health technology | Strong buy |
 ASNDAscendis Pharma A/S Sponsored ADRDR | 12.36 B USD | 204.05 USD | +1.53% | 401.04 K | 0.84 | — | −4.97 USD | +46.81% | 0.00% | Health technology | Strong buy |
 VTRSViatris Inc. | 11.88 B USD | 10.19 USD | +0.79% | 7.01 M | 0.59 | — | −2.91 USD | −435.49% | 4.71% | Health technology | Neutral |
 MRNAModerna, Inc. | 11.08 B USD | 28.49 USD | +0.42% | 8.15 M | 0.70 | — | −7.52 USD | +51.13% | 0.00% | Health technology | Neutral |
 ROIVRoivant Sciences Ltd. | 11.04 B USD | 16.17 USD | +1.19% | 5.3 M | 0.62 | — | −0.70 USD | −112.54% | 0.00% | Health technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 11.02 B USD | 69.15 USD | +1.10% | 2.58 M | 1.16 | — | −1.85 USD | +26.70% | 0.00% | Health technology | Buy |
 EXELExelixis, Inc. | 10.79 B USD | 40.09 USD | −3.05% | 2.21 M | 0.86 | 19.23 | 2.09 USD | +78.54% | 0.00% | Health technology | Buy |
 BMRNBioMarin Pharmaceutical Inc. | 10.64 B USD | 55.43 USD | −0.25% | 2.36 M | 1.01 | 16.42 | 3.38 USD | +154.90% | 0.00% | Health technology | Buy |
 BBIOBridgeBio Pharma, Inc. | 10.11 B USD | 52.86 USD | −0.79% | 1.42 M | 0.60 | — | −4.09 USD | −55.29% | 0.00% | Health technology | Strong buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 9.87 B USD | 443.01 USD | −1.47% | 219.95 K | 0.66 | — | −12.85 USD | +49.62% | 0.00% | Health technology | Strong buy |
 VRNAVerona Pharma plc Sponsored ADRDR | 9.18 B USD | 106.79 USD | −0.03% | 1.97 M | 1.31 | — | −1.03 USD | +33.76% | 0.00% | Health technology | Neutral |
 GRFSGrifols, S.A. Sponsored ADR Class BDR | 8.78 B USD | 9.95 USD | −0.70% | 672.13 K | 1.14 | 20.75 | 0.48 USD | +98.22% | 1.43% | Health technology | Neutral |
 RVMDRevolution Medicines, Inc. | 8.73 B USD | 46.71 USD | +2.21% | 1.78 M | 0.81 | — | −4.50 USD | −23.49% | 0.00% | Health technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 8.46 B USD | 139.48 USD | +1.65% | 1.05 M | 1.35 | — | −6.75 USD | −220.52% | 0.00% | Health technology | Strong buy |
 HALOHalozyme Therapeutics, Inc. | 8.07 B USD | 68.98 USD | −3.78% | 2.66 M | 0.97 | 15.76 | 4.38 USD | +69.71% | 0.00% | Health technology | Buy |
 GHGuardant Health, Inc. | 7.84 B USD | 62.84 USD | +2.25% | 1.83 M | 0.67 | — | −3.35 USD | +18.25% | 0.00% | Health services | Strong buy |
 MRUSMerus N.V. | 7.15 B USD | 94.29 USD | +0.15% | 3.95 M | 0.59 | — | −5.54 USD | −92.92% | 0.00% | Health technology | Neutral |
 RNAAvidity Biosciences, Inc. | 6.86 B USD | 47.00 USD | +6.38% | 1.46 M | 0.61 | — | −3.56 USD | −20.45% | 0.00% | Health technology | Strong buy |
 CYTKCytokinetics, Incorporated | 6.82 B USD | 56.97 USD | +1.15% | 2.46 M | 1.06 | — | −5.12 USD | +4.66% | 0.00% | Health technology | Strong buy |
 RYTMRhythm Pharmaceuticals, Inc. | 6.58 B USD | 99.02 USD | +1.84% | 661.68 K | 0.93 | — | −3.02 USD | +30.87% | 0.00% | Health technology | Strong buy |
 CRSPCRISPR Therapeutics AG | 6.16 B USD | 67.74 USD | −6.98% | 3.68 M | 1.37 | — | −5.42 USD | −68.01% | 0.00% | Health technology | Buy |
 NUVLNuvalent, Inc. | 6.07 B USD | 84.22 USD | +0.43% | 479.98 K | 1.04 | — | −4.90 USD | −76.16% | 0.00% | Health technology | Strong buy |
 AXSMAxsome Therapeutics, Inc. | 6 B USD | 120.30 USD | +0.30% | 322.32 K | 0.73 | — | −5.07 USD | +22.16% | 0.00% | Health technology | Strong buy |
 LEGNLegend Biotech Corp. Sponsored ADRDR | 5.92 B USD | 32.06 USD | −0.71% | 1.93 M | 1.73 | — | −1.77 USD | −13.20% | 0.00% | Health technology | Strong buy |
 PCVXVaxcyte, Inc. | 5.54 B USD | 42.66 USD | +6.30% | 2.4 M | 1.09 | — | −4.19 USD | +11.84% | 0.00% | Health technology | Strong buy |
 KRYSKrystal Biotech, Inc. | 5.31 B USD | 183.36 USD | +0.92% | 397.46 K | 1.04 | 37.30 | 4.92 USD | +34.55% | 0.00% | Health technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 5.19 B USD | 65.37 USD | +3.73% | 2.72 M | 2.44 | 9.37 | 6.97 USD | — | 0.00% | Health technology | Buy |
 ALKSAlkermes plc | 5.13 B USD | 31.06 USD | −0.64% | 1.69 M | 0.85 | 14.91 | 2.08 USD | +23.42% | 0.00% | Health technology | Buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 4.99 B USD | 36.12 USD | +4.39% | 1.96 M | 0.80 | — | −1.26 USD | +72.84% | 0.00% | Health technology | Buy |
 ACLXArcellx, Inc. | 4.72 B USD | 85.07 USD | +3.44% | 924.55 K | 2.06 | — | −3.41 USD | −216.87% | 0.00% | Health technology | Strong buy |
 KYMRKymera Therapeutics, Inc. | 4.14 B USD | 57.90 USD | +3.39% | 612.02 K | 0.57 | — | −3.48 USD | −44.09% | 0.00% | Health technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 4.03 B USD | 64.83 USD | −0.23% | 623.63 K | 0.52 | 90.98 | 0.71 USD | −72.87% | 0.00% | Health technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 3.85 B USD | 40.86 USD | −1.57% | 1.39 M | 0.50 | — | −4.11 USD | −9.10% | 0.00% | Health technology | Strong buy |
 ZLABZai Lab Ltd. Sponsored ADRDR | 3.83 B USD | 33.75 USD | −0.30% | 504.06 K | 0.82 | — | −2.05 USD | +33.47% | 0.00% | Health technology | Strong buy |
 AKROAkero Therapeutics, Inc. | 3.69 B USD | 46.10 USD | −0.67% | 644.71 K | 0.56 | — | −3.80 USD | −11.39% | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 3.68 B USD | 21.80 USD | +1.96% | 1.35 M | 0.48 | 16.38 | 1.33 USD | +645.55% | 0.00% | Health technology | Buy |
 MIRMMirum Pharmaceuticals, Inc. | 3.66 B USD | 72.95 USD | +1.67% | 490.36 K | 0.51 | — | −1.21 USD | +48.34% | 0.00% | Health technology | Strong buy |
 SRRKScholar Rock Holding Corporation | 3.6 B USD | 37.47 USD | +6.48% | 2.1 M | 0.59 | — | −3.02 USD | −29.50% | 0.00% | Health technology | Strong buy |
 LGNDLigand Pharmaceuticals Incorporated | 3.55 B USD | 180.99 USD | +0.48% | 145.68 K | 0.66 | — | −4.00 USD | −272.89% | 0.00% | Health technology | Strong buy |
 ADMAADMA Biologics Inc | 3.5 B USD | 14.66 USD | +0.89% | 2.98 M | 0.85 | 17.26 | 0.85 USD | +504.05% | 0.00% | Health technology | Buy |
 NAMSNewAmsterdam Pharma Company N.V. | 3.45 B USD | 30.67 USD | −0.10% | 966.02 K | 1.09 | — | −1.61 USD | −1,096.60% | 0.00% | Health technology | Strong buy |
 QUREuniQure N.V. | 3.38 B USD | 54.92 USD | +0.77% | 2.82 M | 0.23 | — | −3.92 USD | +33.77% | 0.00% | Health technology | Strong buy |
 AMRXAmneal Pharmaceuticals, Inc. | 3.26 B USD | 10.39 USD | −0.10% | 1.84 M | 1.01 | 1,623.44 | 0.01 USD | — | 0.00% | Health technology | Strong buy |
 CNTACentessa Pharmaceuticals PLC ADRDR | 3.11 B USD | 23.23 USD | +0.78% | 1.01 M | 0.95 | — | −1.78 USD | −14.45% | 0.00% | Health technology | Strong buy |
 XENEXenon Pharmaceuticals Inc. | 3.05 B USD | 39.61 USD | +1.05% | 537.27 K | 0.62 | — | −3.54 USD | −29.45% | 0.00% | Health technology | Strong buy |
 CGONCG Oncology, Inc. | 3.04 B USD | 39.82 USD | −0.09% | 560.5 K | 0.64 | — | −1.68 USD | — | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 3.01 B USD | 31.21 USD | +1.00% | 1.36 M | 0.69 | — | −5.53 USD | +24.18% | 0.00% | Health technology | Strong buy |
 APLSApellis Pharmaceuticals, Inc. | 3.01 B USD | 23.80 USD | +2.99% | 3.51 M | 1.66 | — | −1.82 USD | +33.45% | 0.00% | Health technology | Buy |
 MLYSMineralys Therapeutics, Inc. | 2.95 B USD | 38.06 USD | −5.93% | 958.86 K | 0.61 | — | −3.57 USD | −32.33% | 0.00% | Health technology | Strong buy |
 IMVTImmunovant, Inc. | 2.95 B USD | 16.90 USD | +1.02% | 1.43 M | 0.79 | — | −2.85 USD | −48.38% | 0.00% | Health technology | Buy |
 INDVIndivior PLC | 2.89 B USD | 23.17 USD | −0.39% | 1.17 M | 0.41 | 32.69 | 0.71 USD | — | 0.00% | Health technology | Strong buy |
 HCMHUTCHMED (China) Limited Sponsored ADRDR | 2.87 B USD | 16.09 USD | −0.19% | 68.46 K | 1.20 | 6.00 | 2.68 USD | — | 0.00% | Health technology | Buy |
 KNSAKiniksa Pharmaceuticals, Ltd. | 2.85 B USD | 38.49 USD | +2.72% | 608.92 K | 1.36 | 936.50 | 0.04 USD | — | 0.00% | Health technology | Strong buy |
 VCYTVeracyte, Inc. | 2.83 B USD | 36.00 USD | +1.04% | 724.08 K | 0.65 | 108.21 | 0.33 USD | — | 0.00% | Health technology | Buy |
 TARSTarsus Pharmaceuticals, Inc. | 2.75 B USD | 65.17 USD | +10.89% | 1.32 M | 2.25 | — | −2.33 USD | +48.06% | 0.00% | Health technology | Strong buy |
 SUPNSupernus Pharmaceuticals, Inc. | 2.71 B USD | 48.35 USD | +0.81% | 939.44 K | 1.38 | 42.26 | 1.14 USD | +1,195.81% | 0.00% | Health technology | Buy |
 BEAMBeam Therapeutics Inc. | 2.6 B USD | 25.75 USD | +0.63% | 2.25 M | 1.05 | — | −4.51 USD | −150.05% | 0.00% | Health technology | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 2.53 B USD | 8.20 USD | −0.61% | 6.6 M | 0.95 | — | −0.12 USD | +69.35% | 0.00% | Health technology | Strong buy |
 ALVOAlvotech | 2.51 B USD | 8.32 USD | +1.46% | 193.05 K | 0.40 | 39.64 | 0.21 USD | — | 0.00% | Health technology | Strong buy |
 GLPGGalapagos NV Sponsored ADRDR | 2.46 B USD | 37.62 USD | +4.85% | 604.08 K | 2.94 | — | −4.70 USD | −94.37% | 0.00% | Health technology | Neutral |
 IDYAIDEAYA Biosciences, Inc. | 2.42 B USD | 27.64 USD | +1.62% | 1.31 M | 0.93 | — | −3.79 USD | −73.55% | 0.00% | Health technology | Strong buy |
 OCULOcular Therapeutix, Inc. | 2.42 B USD | 11.41 USD | +3.16% | 8.12 M | 2.26 | — | −1.28 USD | +5.68% | 0.00% | Health technology | Strong buy |
 IBRXImmunityBio, Inc. | 2.4 B USD | 2.54 USD | +1.60% | 15.35 M | 1.81 | — | −0.49 USD | +47.26% | 0.00% | Health technology | Strong buy |
 ARQTArcutis Biotherapeutics, Inc. | 2.39 B USD | 19.92 USD | −6.26% | 2.66 M | 1.23 | — | −0.74 USD | +65.91% | 0.00% | Health technology | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. | 2.39 B USD | 5.49 USD | −0.54% | 49.13 M | 1.16 | — | −1.79 USD | −10.08% | 0.00% | Health technology | Neutral |
 APGEApogee Therapeutics, Inc. | 2.38 B USD | 39.88 USD | +0.68% | 554.41 K | 1.02 | — | −4.08 USD | −79.09% | 0.00% | Health technology | Strong buy |
 GRALGRAIL, Inc. | 2.36 B USD | 65.55 USD | +1.26% | 2.17 M | 1.88 | — | −12.93 USD | +86.08% | 0.00% | Health technology | Neutral |
 IRONDisc Medicine, Inc. | 2.36 B USD | 67.78 USD | +2.92% | 272.22 K | 0.71 | — | −4.48 USD | −22.19% | 0.00% | Health technology | Strong buy |
 AGIOAgios Pharmaceuticals, Inc. | 2.35 B USD | 40.50 USD | +1.43% | 525.44 K | 0.84 | 3.67 | 11.05 USD | — | 0.00% | Health technology | Buy |
 MESOMesoblast Limited Sponsored ADRDR | 2.33 B USD | 18.41 USD | +8.17% | 487.49 K | 1.59 | — | −0.85 USD | +5.09% | 0.00% | Health technology | Strong buy |
 DNLIDenali Therapeutics Inc. | 2.25 B USD | 15.42 USD | +1.45% | 1.42 M | 0.58 | — | −2.81 USD | +1.62% | 0.00% | Health technology | Strong buy |
 SRPTSarepta Therapeutics, Inc. | 2.21 B USD | 22.64 USD | +1.30% | 8.32 M | 1.24 | — | −0.76 USD | −287.54% | 0.00% | Health technology | Neutral |
 ETNB89bio, Inc. | 2.2 B USD | 14.85 USD | +0.07% | 1.7 M | 0.18 | — | −3.61 USD | −82.75% | 0.00% | Health technology | Buy |
 COGTCogent Biosciences, Inc. | 2.2 B USD | 15.76 USD | +6.85% | 2.22 M | 1.02 | — | −2.42 USD | +2.25% | 0.00% | Health technology | Buy |
 TVTXTravere Therapeutics, Inc. | 2.2 B USD | 24.64 USD | +1.73% | 1.25 M | 0.60 | — | −2.04 USD | +57.84% | 0.00% | Health technology | Strong buy |
 ADPTAdaptive Biotechnologies Corporation | 2.19 B USD | 14.38 USD | +0.98% | 2.13 M | 0.91 | — | −0.81 USD | +44.48% | 0.00% | Health technology | Strong buy |
 NTLAIntellia Therapeutics, Inc. | 2.14 B USD | 19.96 USD | −2.35% | 5.78 M | 0.77 | — | −4.69 USD | +14.42% | 0.00% | Health technology | Buy |
 ANIPANI Pharmaceuticals, Inc. | 1.95 B USD | 89.64 USD | +0.57% | 277.48 K | 0.84 | — | −0.77 USD | −162.85% | 0.00% | Health technology | Strong buy |
 VERAVera Therapeutics, Inc. | 1.92 B USD | 30.14 USD | +3.25% | 981.26 K | 0.59 | — | −3.58 USD | −62.51% | 0.00% | Health technology | Strong buy |
 TWSTTwist Bioscience Corporation | 1.88 B USD | 31.07 USD | +1.27% | 1.97 M | 1.21 | — | −1.45 USD | +61.94% | 0.00% | Health technology | Strong buy |